FDA-Drug2021-07-21Class II

NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA

The Harvard Drug Group
Hazard

Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.

Sold states
Distributed in OH and NJ
Affected count
504 Cartons of 50 count each; 372 Cartons of 100 count each
Manufactured in
17187 N Laurel Park Dr Ste 300, Livonia, MI, United States
Products
NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0652-2021

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief